A detailed history of Freedom Wealth Alliance, LLC transactions in Talaris Therapeutics, Inc. stock. As of the latest transaction made, Freedom Wealth Alliance, LLC holds 16,145 shares of TALS stock, worth $43,914. This represents 0.07% of its overall portfolio holdings.

Number of Shares
16,145
Holding current value
$43,914
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$2.68 - $3.22 $43,268 - $51,986
16,145 New
16,145 $45.4 Million

Others Institutions Holding TALS

About Talaris Therapeutics, Inc.


  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Freedom Wealth Alliance, LLC Portfolio

Follow Freedom Wealth Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedom Wealth Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freedom Wealth Alliance, LLC with notifications on news.